Botanical species · safety record

Lophophora williamsii

The EFSA Compendium of Botanicals holds 12 constituent measurements and 1 adverse-effect record for Lophophora williamsii. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lophophora williamsii (Lem. ex Salm-Dyck) J.M.Coult.

12Constituent measurements
1Safety records
6Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Mescaline7
  • Alkaloids1
  • Homopiperonylamine1
  • Isoquinoline alkaloids1
  • Lobivine1
  • Lophophine1

Plant parts

  • Live plants6
  • Aerial part of plants4
  • Stem2
  • stalk2

Preparations

  • Solvent extraction8
  • Fresh1

Effect types

  • Neurotoxicity1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsLive plantsSolvent extractionHPLC-DADResolve DOI
Isoquinoline alkaloidsLive plantsSolvent extractionHPLC-DADResolve DOI
MescalineLive plantsSolvent extraction≥ 680 Milligram/100 gramHPLC-DADResolve DOI
MescalineLive plantsSolvent extraction≤ 1010 Milligram/100 gramHPLC-DADResolve DOI
MescalineStem / stalkSolvent extraction≥ 12.7 Milligram/gramHPLC with standard detection methodsResolve DOI
MescalineStem / stalkSolvent extraction≤ 48.3 Milligram/gramHPLC with standard detection methodsResolve DOI
HomopiperonylamineAerial part of plantsNo resolvable identifier
LobivineAerial part of plantsNo resolvable identifier
LophophineAerial part of plantsNo resolvable identifier
MescalineLive plantsSolvent extraction≥ 0.0147 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
MescalineLive plantsSolvent extraction≤ 5.5 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
MescalineAerial part of plantsFresh2.55 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
NeurotoxicityHuman (as organism)Case reportResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. HELMLIN, HJ., BOURQUIN, D., BRENNEISEN, R. DETERMINATION OF PHENYLETHYLAMINES IN HALLUCINOGENIC CACTUS SPECIES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH PHOTODIODE-ARRAY DETECTION . Journal of chromatography, 1992, vol. 623, no. 2, p. 381-385. DOI
  2. Carstairs, Shaun D., Cantrell, F. Lee. Peyote and mescaline exposures: a 12-year review of a statewide poison center database . Clinical toxicology, 2010, vol. 48, no. 4, p. 350-353. DOI
  3. Bruhn, Jan G., El-Seedi, Hesharn R., Stephanson, Nikolai., Beck, Olof., Shulgin, Alexander T. Ecstasy analogues found in cacti. Journal of psychoactive drugs, 2008, vol. 40, no. 2, p. 219-222.
  4. Klein, Molly T., Kalam, M., Trout, Keeper., Fowler, Norma., Terry, Martin. MESCALINE CONCENTRATIONS IN THREE PRINCIPAL TISSUES OF LOPHOPHORA WILLIAMSII (CACTACEAE): IMPLICATIONS FOR SUSTAINABLE HARVESTING PRACTICES . Haseltonia, 2015, no. 20, p. 34-42.
  5. Aragane, Masako., Sasaki, Yohei., Nakajima, Jun'ichi., Fukumori, Nobutaka., Yoshizawa, Masao., Suzuki, Yukiko., Kitagawa, Shigemi., Mori, Ken'ichiro., Ogino, Shuzo., Yasuda, Ichiro., Nagumo, Seiji. Peyote identification on the basis of differences in morphology, mescaline content, and trnL/trnF sequence between Lophophora williamsii and L. diffusa . Journal of natural medicines, 2011, vol. 65, no. 1, p. 103-110. DOI
  6. Gennaro, MC., Gioannini, E., Giacosa, D., Siccardi, D. Determination of mescaline in hallucinogenic Cactaceae by ion-interaction HPLC. . Analytical letters, 1996, vol. 29, no. 13, p. 2399-2409.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue